179 related articles for article (PubMed ID: 36699142)
1. Planning for decentralized, simplified prEP: Learnings from potential end users in Ga-Rankuwa, gauteng, South Africa.
Mataboge P; Nzenze S; Mthimkhulu N; Mazibuko M; Kutywayo A; Butler V; Naidoo N; Mullick S
Front Reprod Health; 2022; 4():1081049. PubMed ID: 36699142
[TBL] [Abstract][Full Text] [Related]
2. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
4. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
5. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
[TBL] [Abstract][Full Text] [Related]
6. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
[TBL] [Abstract][Full Text] [Related]
7. Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women.
O'Malley G; Beima-Sofie KM; Roche SD; Rousseau E; Travill D; Omollo V; Delany-Moretlwe S; Bekker LG; Bukusi EA; Kinuthia J; Barnabee G; Dettinger JC; Wagner AD; Pintye J; Morton JF; Johnson RE; Baeten JM; John-Stewart G; Celum CL
Front Reprod Health; 2021; 3():668672. PubMed ID: 36303982
[No Abstract] [Full Text] [Related]
8. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya.
Wara NJ; Mvududu R; Marwa MM; Gómez L; Mashele N; Orrell C; Moucheraud C; Kinuthia J; John-Stewart G; Myer L; Hoffman R; Pintye J; Davey DLJ
J Int AIDS Soc; 2023 May; 26(5):e26088. PubMed ID: 37221983
[TBL] [Abstract][Full Text] [Related]
9. The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery.
Henderson M; Schmidt HA; Chitembo L; Peralta H; Alaama AS; Johnson C; Baggaley R; Schaefer R
AIDS Behav; 2023 Nov; 27(11):3755-3766. PubMed ID: 37351685
[TBL] [Abstract][Full Text] [Related]
10. Advancing the use of Long-Acting Extended Delivery formulations for HIV prevention in sub-Saharan Africa: challenges, opportunities, and recommendations.
Mgodi NM; Murewanhema G; Moyo E; Samba C; Musuka G; Dzinamarira T; Brown JM
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26115. PubMed ID: 37439069
[TBL] [Abstract][Full Text] [Related]
11. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
[TBL] [Abstract][Full Text] [Related]
12. End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa.
Brown MS; Hanif H; Little KM; Clark MR; Thurman AR; Flomen L; Doncel GF
BMC Infect Dis; 2022 Dec; 22(1):919. PubMed ID: 36482336
[TBL] [Abstract][Full Text] [Related]
13. Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.
Hendrickson C; Hirasen K; Mongwenyana C; Benade M; Bothma R; Smith C; Meyer J; Nichols B; Long L
medRxiv; 2023 Aug; ():. PubMed ID: 37645864
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
[TBL] [Abstract][Full Text] [Related]
15. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology.
Ismail A; Magni S; Katahoire A; Ayebare F; Siu G; Semitala F; Kyambadde P; Friedland B; Jarrahian C; Kilbourne-Brook M
PLoS One; 2023; 18(8):e0290568. PubMed ID: 37651432
[TBL] [Abstract][Full Text] [Related]
16. Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study.
Mpunga E; Persaud N; Akolo C; Boyee D; Kamanga G; Trapence G; Chilongozi D; Ruberintwari M; Masankha Banda L
JMIR Public Health Surveill; 2021 Oct; 7(10):e26177. PubMed ID: 34228627
[TBL] [Abstract][Full Text] [Related]
17. Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis.
Pike C; Rousseau E; Bekker LG
South Afr J HIV Med; 2023; 24(1):1497. PubMed ID: 38089889
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of South African youth in the development of an implant for HIV prevention.
Krogstad EA; Atujuna M; Montgomery ET; Minnis A; Ndwayana S; Malapane T; Shapley-Quinn MK; Manenzhe K; Bekker LG; van der Straten A
J Int AIDS Soc; 2018 Aug; 21(8):e25170. PubMed ID: 30152004
[TBL] [Abstract][Full Text] [Related]
19. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
20. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
